Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Find out if you're a candidate for bariatric (weight loss) surgery
As of April 2025, the FDA had received 520 adverse event reports related to compounded semaglutide and 480 reports concerning compounded tirzepatide
In its approved and experimental uses, significantly higher doses of oral semaglutide are required daily due to the relative instability of semaglutide in gastric juices
If Foundayo's clinical outcomes hold up in real-world use (the Phase 3 ATTAIN-1 trial showed 11.2% mean weight loss at 72 weeks on the 36 mg dose, or 12.4% among participants who stayed on treatment), it could become the go-to affordable GLP-1 option and put downward pressure on Wegovy and Zepbound pricing
US$ 23.31
US$ 24.76
US$ 25.44
US$ 21.99
US$ 26.49
US$ 29.45
US$ 23.39
US$ 21.24
US$ 27.75
US$ 23.25
US$ 25.75
US$ 24.32
